Skip to content

Net margin at other companies

Gilead Sciences logo
Gilead SciencesGILD
31%+10.2pp
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-93.3%-18.2pp
Arrowhead Research logo
Arrowhead ResearchARWR
-48.4%+240pp
LQD
Liquidia CorporationLQDA
-176.2%-76.4pp
Alkermes logo
AlkermesALKS
9.8%-13.5pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-30.9%-10.5pp

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s net margin?
Mirum Pharmaceuticals, Inc. (MIRM) reported net margin of -140.2% in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s net margin changed year-over-year?
Mirum Pharmaceuticals, Inc.'s net margin decreased by 587.7% year-over-year, from -20.4% to -140.2%.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net margin?
Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s net margin has grown at a -70.6% compound annual growth rate (CAGR), from -176% to -4.5%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.